A federal judge decided Friday to not throw out renewed lawsuits against Visa and MasterCard over their interchange fees, allowing the suits filed by various merchants that opted out of the credit card giants’ $5.7 billion settlement to proceed.
Visa and MasterCard had filed a motion to have more than 30 lawsuits dismissed. The cases were filed by companies including Target, Macy’s and Wal-Mart after the stores opted out of the record-setting settlement offer.
Retailers revised their suits against the credit card firms earlier this month and, in a filing, argue that the firms “have obtained and maintained market power in the market for merchant acceptance of credit cards,” and that the credit card companies have strong-armed merchants into paying “excessive interchange fees.”
In a similar lawsuit, Wal-Mart is seeking $4 billion in damages from Visa for such swipe-fees on grounds that “Visa’s monopoly power has enabled it to dictate price and inhibit competition.”
US District Judge John Gleeson decided not to toss the new lawsuits after approving Visa and MasterCard’s proposed settlement offer last December.
While a small victory for the merchants, Judge Gleeson also decided not to dismiss countersuits filed by Visa and MasterCard against Wal-Mart and other retailers aimed at stopping the litigation against the swipe-fees.
Full content: Bloomberg
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
Featured News
Trump Administration Steps Up Pressure On EU Digital Laws
May 18, 2025 by
CPI
Elton John Slams UK Government’s AI Copyright Plan as ‘Theft’
May 18, 2025 by
CPI
Anthropic’s Legal Team Blames AI “Hallucination” for Citation Error in Copyright Lawsuit
May 18, 2025 by
CPI
Intel Challenges €376 Million EU Antitrust Fine in Ongoing Legal Battle
May 18, 2025 by
CPI
FTC Chairman Highlights Fiscal Responsibility and Consumer Protection in House Testimony
May 18, 2025 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Healthcare Antitrust
May 14, 2025 by
CPI
Healthcare & Antitrust: What to Expect in the New Trump Administration
May 14, 2025 by
Nana Wilberforce, John W O'Toole & Sarah Pugh
Patent Gaming and Disparagement: Commission Fines Teva For Improperly Protecting Its Blockbuster Medicine
May 14, 2025 by
Blaž Višnar, Boris Andrejaš, Apostolos Baltzopoulos, Rieke Kaup, Laura Nistor & Gianluca Vassallo
Strategic Alliances in the Pharma Sector: An EU Competition Law Perspective
May 14, 2025 by
Christian Ritz & Benedikt Weiss
Monopsony Power in the Hospital Labor Market
May 14, 2025 by
Kevin E. Pflum & Christian Salas